Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 29, 2017
goBalto, Inc., a provider of cloud-based clinical study startup solutions, announced results from its ongoing partnership with INC Research, a global CRO and pioneer in the implementation of goBalto's end-to-end study startup platform to accelerate ...
read more
Wednesday, March 29, 2017
Genstar Capital, a middle-market private equity firm focused on investments in targeted segments of the healthcare, financial services, software, and industrial technology industries, has acquired Bracket, a scientifically-driven clinical trial ...
read more
Wednesday, March 29, 2017
Warp Drive Bio, Inc., a life sciences company developing therapeutics that exploit the molecules and mechanisms of nature, has announced a collaboration with GSK, which combines Warp Drive’s Small Molecule-Assisted Receptor Targeting (SMART™) ...
read more
Cota Healthcare, a data and technology platform for value-based precision medicine, today announced the signing of a major, multi-year collaboration with Novartis Pharmaceuticals Corporation to help improve clinical and cost outcomes for breast ...
read more
Dr. Reddy's Laboratories Limited and Integra LifeSciences Holdings Corporation have entered into an exclusive distribution agreement. Under the agreement, Dr. Reddy’s will market and distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration ...
read more
TraceLink Inc. has announced a partnership with Advanco to support pharmaceutical manufacturers with the integration of line management and enterprise systems when complying with new serialization regulations.
read more
Invivotek, LLC, a Genesis Biotechnology Group® (GBG) company and in vivo pharmacology contract research organization (CRO), announced the completion of the Genesis Solar Farm adjacent to its newly expanded preclinical research facility in Hamilton, ...
read more
ShangPharma, a life science partnering organization providing drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced the intent for a strategic corporate restructuring.
read more
Permira, a global private equity firm, has announced that a company backed by the Permira funds has signed a definitive agreement to acquire Lyophilization Services of New England, Inc (“LSNE”), a contract development and manufacturing organization ...
read more
Impax Laboratories, Inc. announced that its Board of Directors has appointed Paul M. Bisaro as Impax's President and Chief Executive Officer and a member of the Company's Board, effective March 27, 2017. Mr. Bisaro will succeed J. Kevin Buchi, who ...
read more
Recipharm has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery of Emla™ Patch to Japan.
read more
SGS has announced that it has invested in multiple highly sensitive and selective LC-MS/MS instruments at its Poitiers, France laboratory, for the quantification of proteins and peptide therapeutics.
read more
Avista Pharma Solutions, Inc has announced that the $4 million expansion of its 26,000-square foot contract testing facility in Agawam, Massachusetts is now complete. For over 30 years, the Agawam site has provided superior service to pharmaceutical ...
read more
Eurofins Scientific has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment.
read more
Cellaria, LLC has announced the expansion of its offerings to include a suite of stem cell services. The initiative advances Cellaria’s mission to provide more accurate patient and disease-specific cell models to help researchers focus and accelerate...
read more